Incannex Healthcare has recently received authorization from the FDA to advance to Phase 2 of their clinical trial focusing on psilocybin-assisted psychotherapy for Generalized Anxiety Disorder (GAD). Psilocybin, a compound found in certain mushrooms, is currently being investigated for its potential therapeutic benefits. This trial...
If you’ve ever thought about trying MDMA, you might be surprised to learn that there’s not just one version of this popular molecule. Meet S-MDMA and R-MDMA, the mirror-image twins of the MDMA family! While they share a last name, these two are quite different...
Have you ever wondered what could be the next big thing in concussion recovery? Well, recent research is giving us a peek into an exciting possibility: psychedelic therapy. Athletes and sports trainers are starting to consider psychedelics as a potential tool for healing from concussions....
Psychedelic therapy is gaining traction as a potential game-changer in mental health treatment. But what makes classic psychedelics different from MDMA (often known as ecstasy), especially when it comes to our brain’s executive functions, attention, and memory? Let’s break down the science behind these substances...